Cargando…

Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France

BACKGROUND: Most European health care systems are suffering from the impact of demographic change. In short, aging of society is leading to higher costs of treatment per capita, while reproduction rates below 2.1 children per woman lead to a reduced number of younger people to provide for the necess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boecking, Wolfgang, Klamar, Anna, Kitzmann, Florian, Kirch, Wilhelm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529195/ https://www.ncbi.nlm.nih.gov/pubmed/23092314 http://dx.doi.org/10.1186/1471-2458-12-894

Ejemplares similares

Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France
por: Heinzlef, Olivier, et al.
Publicado: (2020)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Pharmaco-economics: Minute-based cost of sevoflurane in pediatric short procedures and its relation to demographic variables
por: Singh, Preet Mohinder, et al.
Publicado: (2013)

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value
por: Zoons, E., et al.
Publicado: (2012)

Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders
por: Greenberg, Paul E., et al.
Publicado: (2021)

Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
por: Schneider, John E., et al.
Publicado: (2018)

International Pharmaceutical Spending Controls: France, Germany, Sweden, and the United Kingdom
por: Gross, David J., et al.
Publicado: (1994)

Obesity Is Associated with an Increase in Pharmaceutical Expenses among University Employees
por: Gazmararian, Julie A., et al.
Publicado: (2015)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Pharmaco-prosthodontics revisited
por: Jagadeeshwaran, A. R., et al.
Publicado: (2012)

Current process and future path for health economic assessment of pharmaceuticals in France
por: Toumi, Mondher, et al.
Publicado: (2015)

PHARMACO – THERAPEUTICS OF DASEMANI DRUGS
por: Sircar, N. N.
Publicado: (1984)

ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)

COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future
por: Donner, Claudio F, et al.
Publicado: (2010)

The Impact of Two-Invoice System on Pharmaceutical Manufacturers’ Selling Expenses in China: A Difference-in-Differences Approach
por: Ran, Yi, et al.
Publicado: (2022)

From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
por: Bajcar, Jana M, et al.
Publicado: (2010)

Cognitive Effects of Montelukast: A Pharmaco-EEG Study
por: Schwimmbeck, Fabian, et al.
Publicado: (2021)

Facilitated/Pharmaco-invasive Approaches in STEMI
por: Capodanno, Davide, et al.
Publicado: (2012)

Epigenetics and pharmaco-epigenetics in the primary headaches
por: Montagna, Pasquale
Publicado: (2008)

Pharmaco-Immunomodulatory Therapy in COVID-19
por: Rizk, John G., et al.
Publicado: (2020)

Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approach
por: Wilke, MH, et al.
Publicado: (2010)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

Critical economics of life and death: Intense + Expensive care = Intensive care?
por: Ramakrishnan, Nagarajan
Publicado: (2013)

Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment
por: Toumi, Mondher, et al.
Publicado: (2017)

Pharmaco-management of inhalation injuries for burn survivors
por: Bartley, Anthony C, et al.
Publicado: (2009)

Pharmaco-genomics and anaesthesia: Mysteries, correlations and facts
por: Bhaskar, S Bala, et al.
Publicado: (2013)

Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis
por: Buysschaert, Ian, et al.
Publicado: (2008)

Quantitative Pharmaco-Electroencephalography in Antiepileptic Drug Research
por: Höller, Yvonne, et al.
Publicado: (2018)

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

The Baths of Germany, France, and Switzerland
Publicado: (1857)

The Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1859)

Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
por: Nagata, Tomohisa, et al.
Publicado: (2018)

A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours
por: Contreras-Hernández, I, et al.
Publicado: (2008)

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss
por: Treur, Maarten, et al.
Publicado: (2009)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study
por: Horn, Johannes, et al.
Publicado: (2018)

Options for Change under Medicare: Impact of a Cap on Catastrophic Illness Expense
por: Gornick, Marian, et al.
Publicado: (1983)

Socio-demographic and socio-economic disparities in medical rehabilitation in Germany in 2019: Silke Kniffert
por: Kniffert, S, et al.
Publicado: (2022)

Expenses of Administration
Publicado: (1913)

Expensive Treatment
Publicado: (1883)

Cannot write session to /tmp/vufind_sessions/sess_bkgm3djg00ga5dvijnacmvp707